Swiss-based Deep Cube Announces Collaboration With University Hospital Of Geneva To Develop Highly Efficient Artificial Intelligence-based Algorithms For Accurately Diagnosing Early Stage Alzheimer’s Disease

Founded in 2018 and based in Lausanne Epalinges at BIOPOLE in Switzerland, Deep Cube SA specializes in developing innovative artificial intelligence (AI) technology based on Deep Learning. The company operates in two focus areas, one in analyzing skin disorders such as skin melanoma and skin non-melanoma and the other in diagnosing human brain PET scans for Alzheimer’s disease. Deep Cube is the recipient of several prestigious awards and industry prizes: 2017 Best AI Award at the Multimodal Emotion Recognition Challenge (MEC), best AI Award at the 2018 Convention on Computer Vision and Pattern Recognition (CVPR), First Prize at the 2019 Consumer Electronics Show (CES ASIA) and Second Prize at the 2019 World AI Conference (WAIC) and including a recent world record in mathematics with HPC computing on HPE’s APOLLO 6500 Server for the computation of Phi (the golden ratio) with 20,000,000,000 digits, executed in only 6.9 days.

More information is available at

* Source Journal of Nuclear Medicine (JNN) Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

Nicolaas I. Bohnen, David S.W. Djang, Karl Herholz5, Yoshimi Anzai and Satoshi Minoshima


For any country outside of the USA

Chris Patris de Broe

Deep Cube SA

Lausanne Epalinges, Switzerland

Telephone: +41 (0)78 631 50 20


Edward D. Agne

The Communications Strategy Group Inc.

Boston, Massachusetts

Telephone: +1 781 631 3117

Mobile: +1 781 888 0099

Back to news